SCHEMBL6316573

SCHEMBL6316573

[CH2]CC([CH2])C(C)(C)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2231928 0.74
SCHEMBL1973430 0.72
SCHEMBL27963072 0.72
SCHEMBL17607445 0.72
SCHEMBL27686655 0.70
SCHEMBL27936409 0.70
SCHEMBL591726 0.70
SCHEMBL17607768 0.70
SCHEMBL17607650 0.68
SCHEMBL8746343 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050238616-A1 Compositions for treatment of central nervous system neoplasms, and methods of making and using the same GUILFORD PHARMACEUTICALS, INC. (US) 2005-10-27 US disclosed
US-20040197301-A1 Hybrid polymers and methods of making the same EISAI INC. 2004-10-07 US disclosed
WO-2002005800-A9 COMPOSITIONS FOR SUSTAINED RELEASE OF ANALGESIC AGENTS, AND METHODS OF MAKING AND USING THE SAME GUILFORD PHARM INC (US) 2003-08-28 WO disclosed
WO-2003060799-A2 COMPOSITIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM NEOPLASMS, AND METHODS OF MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS, INC. (US) 2003-07-24 WO disclosed
US-20030133903-A1 Compositions for treatment of prostate cancers and methods of making and using the same GUILFORD PHARMACEUTICALS, INC. 2003-07-17 US disclosed
US-20030134892-A1 Compositions for treatment of head and neck cancers, and methods of making and using the same GUILFORD PHARMACEUTICALS, INC. 2003-07-17 US disclosed
WO-2003007915-A2 COMPOSITIONS FOR TREATMENT OF HEAD AND NECK CANCERS, AND METHODS OF MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS, INC. (US) 2003-01-30 WO disclosed
WO-2003007914-A2 BIOCOMPATIBLE POLYMER CONTAINING COMPOSITION FOR TREATMENT OF PROSTATE CANCERS GUILFORD PHARMACEUTICALS, INC. (US) 2003-01-30 WO disclosed
US-20020198135-A1 Compositions for release of radiosensitizers, and methods of making and using the same JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE 2002-12-26 US disclosed
US-20020141966-A1 Compositions for treatment of malignant effusions, and methods of making and using the same GUILFORD PHARMACEUTICALS, INC. 2002-10-03 US disclosed
US-6455665-B1 ETHYL OR HEXYL DICHLOROPHOSPHATE OR DICHLOROPHOSPHONATE REACTED WITH A POLYESTER PREPOLYMER GUILFORD PHARMACEUTICALS INC. 2002-09-24 US disclosed
WO-2002040001-A2 COMPOSITIONS FOR TREATMENT OF MALIGNANT EFFUSIONS COMPRISING A BIOCOMPATIBLE POLYMER AND ANTINEOPLASTIC TAXANE GUILFORD PHARMACEUTICALS INC. (US) 2002-05-23 WO disclosed
US-20020045668-A1 Compositions for sustained release of analgesic agents, and methods of making and using the same GUILFORD PHARMACEUTICALS, INC. 2002-04-18 US disclosed
WO-2002030472-A2 COMPOSITIONS FOR RELEASE OF RADIOSENSITIZERS, AND METHODS OF MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS, INC. (US) 2002-04-18 WO disclosed
US-20020041897-A1 Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same GUILFORD PHARMACEUTICALS, INC. 2002-04-11 US disclosed
US-20020028911-A1 Ethyl or hexyl dichlorophosphate or dichlorophosphonate reacted with a polyester prepolymer EISAI INC. 2002-03-07 US disclosed
WO-2002005800-A2 COMPOSITIONS FOR SUSTAINED RELEASE OF ANALGESIC AGENTS, AND METHODS OF MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS, INC. (US) 2002-01-24 WO disclosed
WO-2002003957-A2 COMPOSITIONS FOR SUSTAINED RELEASE OF ANTINEOPLASTIC TAXANES, AND METHODS OF MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS, INC. (US) 2002-01-17 WO disclosed
WO-2002004544-A2 POLYMERS AND POLYMERIZATION PROCESSES GUILFORD PHARMACEUTICALS (US) 2002-01-17 WO disclosed